Zum Inhalt springen

Schlagwort: Vitamin-K-Antagonist

Leitlinie „Evaluation and Management of Acute Pulmonary Embolism in Adults“ der AHA & ACC

Leitlinie „Evaluation and Management of Acute Pulmonary Embolism in Adults“ der AHA & ACC

Published on 26. Februar 2026

veröffentlichende Fachgesellschaft: American Heart Association (AHA), American College of Cardiology (ACC), American College of Clinical Pharmacy (ACCP), American College of Emergency Physicians (ACEP), American College…

Leitlinie „Definition of factor Xa inhibitor-related, life-threatening gastrointestinal bleeding and guidance on when to use reversal therapy“

Leitlinie „Definition of factor Xa inhibitor-related, life-threatening gastrointestinal bleeding and guidance on when to use reversal therapy“

Published on 12. Januar 2024

Zusammenfassung der Leitlinie „Definition of factor Xa inhibitor–related, life-threatening gastrointestinal bleeding and guidance on when to use reversal therapy“ aus dem Oktober 2023

Leitlinie „Management of major bleeding for anticoagulated patients in the Emergency Department“ der EUSEM

Leitlinie „Management of major bleeding for anticoagulated patients in the Emergency Department“ der EUSEM

Published on 12. September 2023

Zusammenfassung der Leitlinie „Management of major bleeding for anticoagulated patients in the Emergency Department“ aus dem Oktober 2023